Beam Share Price

Beam Share Price

NASDAQ: BEAM | Mid Cap | Healthcare
$20.92
-$0.02 (-0.12%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Beam Stock Performance

Open
$20.65
Prev. Close
$20.95
Circuit Range
N/A
Day Range
$20.56 - $22.05
Year Range
$20.23 - $38.16
Volume
1,82,462
Average Traded
$21.08

Beam Share Price Today

As of 22 November 2026, Beam Therapeutics Inc.'s share price is $20.92. The stock opened at $20.65, compared to its previous close of $20.95. During today's trading session, Beam Therapeutics Inc.'s share price traded between $20.56 and $22.05, with an average price of $21.30. Over the past 52 weeks, the stock has recorded a high of $38.16 and a low of $20.23. In terms of performance, Beam Therapeutics Inc.'s share price has declined by 36.49% over the last six months and is down 17.43% on a year-on-year basis.

Beam Share Price Chart

Line chart of the Beam price trend over the selected period. The price fell overall, ranging from 20.59 to 22.04, ending at 20.93.
$20.56$22.05
L
Show Current Price
H

Beam Stock Fundamentals & Key Indicators

Market Cap
$2.07B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.03
Revenue (TTM)
$139.74B
Return On Equity (TTM)
-11.24%
Profit Margin
-57.24%
Debt to Equity
0.11
Quarterly Earnings Growth YoY
-155.02%

Beam Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$114.11$31.74$0.49$0.31
Net Profit$244.30-$94.32-$122.68-$134.41
Net Profit Margin214.09%-297.16%-25036.73%-43358.06%
Income ChangeN/A-138.61%-30.07%-9.56%

Beam Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$60.92$377.71$63.52$139.74
Net Profit-$289.09-$132.53-$376.74-$79.99
Net Profit Margin-474.54%-35.09%-593.10%-57.24%
Income ChangeN/A54.16%-184.27%78.77%

Beam Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets212.49225.68248.67248.82
Current Assets1268.69878.151211.041092.9
Total Assets1481.181103.821459.711341.71
Non Current Liabilities145.88188.21272.82384.65
Current Liabilities96.94182.07205.57223.6
Total Liabilities242.82370.28478.39608.24
Shareholders' Equity1238.36733.55981.33733.47

Beam Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-345.1-347.25-149.241.43
Investing-121.44185.0171.84-461.34
Financing478.057.74276.4592.69

About Beam

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Beam Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$27.50
$20.86
-23.32%
Oct 2026
$23.97
$27.21
+11.11%
Sep 2026
$29.02
$24.49
-19.55%
Aug 2026
$25.55
$30.44
+19.42%
Jul 2026
$34.67
$25.49
-25.69%
Jun 2026
$32.31
$34.30
+4.13%
May 2026
$29.93
$32.94
+8.68%
Apr 2026
$24.35
$30.31
+27.27%
Mar 2026
$27.50
$23.82
-16.38%
Feb 2026
$27.24
$28.48
+3.15%
Jan 2026
$27.63
$27.61
-0.36%
Dec 2025
$24.91
$27.71
+9.37%

Beam Share Price FAQs